Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Heck

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
The Journal of Urology|February 4, 2021
Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational StudyThomas Amiel, Christoph Würnschimmel, Matthias Heck, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 18, 2009
Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitisLutz Schneider, Werner Hartwig, Thomas Flemming, et al.
The Journal of Urology|December 20, 2015
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate CancerTobias Maurer, Jürgen E Gschwend, Isabel Rauscher, et al.
Asian Journal of Urology|February 24, 2022
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancerChrista Babst, Thomas Amiel, Tobias Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2022
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective StudyHarun Ilhan, Markus Kroenke, Alexander Wurzer, et al.
World Journal of Urology|January 12, 2023
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-studyChrister Groeben, Katharina Boehm, Rainer Koch, et al.
European Urology|December 9, 2020
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMABenedikt Feuerecker, Robert Tauber, Karina Knorr, et al.
European Urology|April 17, 2019
Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate CancerThomas Horn, Markus Krönke, Isabel Rauscher, et al.
World Journal of Urology|August 20, 2022
Ultrasound-based "CEUS-Bosniak"classification for cystic renal lesions: an 8-year clinical experienceElena Herms, Gregor Weirich, Tobias Maurer, et al.
European Urology|March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)Robert Seifert, Louise Emmett, Steven P Rowe, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Urology|February 4, 2021
Regional Lymph Node Metastasis on Prostate Specific Membrane Antigen Positron Emission Tomography Correlates with Decreased Biochemical Recurrence-Free and Therapy-Free Survival after Radical Prostatectomy: A Retrospective Single-Center Single-Arm Observational StudyThomas Amiel, Christoph Würnschimmel, Matthias Heck, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 18, 2009
Protective effects and anti-inflammatory pathways of exogenous calcitonin gene-related peptide in severe necrotizing pancreatitisLutz Schneider, Werner Hartwig, Thomas Flemming, et al.
The Journal of Urology|December 20, 2015
Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate CancerTobias Maurer, Jürgen E Gschwend, Isabel Rauscher, et al.
Asian Journal of Urology|February 24, 2022
Cytoreductive radical prostatectomy after chemohormonal therapy in patients with primary metastatic prostate cancerChrista Babst, Thomas Amiel, Tobias Maurer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2022
<sup>18</sup>F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective StudyHarun Ilhan, Markus Kroenke, Alexander Wurzer, et al.
World Journal of Urology|January 12, 2023
Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-studyChrister Groeben, Katharina Boehm, Rainer Koch, et al.
European Urology|December 9, 2020
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMABenedikt Feuerecker, Robert Tauber, Karina Knorr, et al.
European Urology|April 17, 2019
Single Lesion on Prostate-specific Membrane Antigen-ligand Positron Emission Tomography and Low Prostate-specific Antigen Are Prognostic Factors for a Favorable Biochemical Response to Prostate-specific Membrane Antigen-targeted Radioguided Surgery in Recurrent Prostate CancerThomas Horn, Markus Krönke, Isabel Rauscher, et al.
World Journal of Urology|August 20, 2022
Ultrasound-based "CEUS-Bosniak"classification for cystic renal lesions: an 8-year clinical experienceElena Herms, Gregor Weirich, Tobias Maurer, et al.
European Urology|March 19, 2023
Second Version of the Prostate Cancer Molecular Imaging Standardized Evaluation Framework Including Response Evaluation for Clinical Trials (PROMISE V2)Robert Seifert, Louise Emmett, Steven P Rowe, et al.
Pageof 4